These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34477535)

  • 1. Approaches for Ear-targeted Delivery Systems in Neurosensory Disorders to avoid Chronic Hearing Loss Mediated Neurological Diseases.
    Verma R; Vyas P; Kaur J; Javed MN; Sarafroz M; Ahmad M; Gilani SJ; Taleuzzaman M
    CNS Neurol Disord Drug Targets; 2022; 21(6):479-491. PubMed ID: 34477535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticle-based drug delivery in the inner ear: current challenges, limitations and opportunities.
    Mittal R; Pena SA; Zhu A; Eshraghi N; Fesharaki A; Horesh EJ; Mittal J; Eshraghi AA
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1312-1320. PubMed ID: 30987439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advancements in the studies of novel nanomaterials for inner ear drug delivery.
    Zhang L; Bai X; Wang R; Xu L; Ma J; Xu Y; Lu Z
    Nanomedicine (Lond); 2022 Aug; 17(20):1463-1475. PubMed ID: 36189895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of nanoparticle drug-delivery systems for the inner ear.
    An X; Zha D
    Nanomedicine (Lond); 2020 Aug; 15(20):1981-1993. PubMed ID: 32605499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inner ear drug delivery: Recent advances, challenges, and perspective.
    Hao J; Li SK
    Eur J Pharm Sci; 2019 Jan; 126():82-92. PubMed ID: 29792920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled drug release to the inner ear: Concepts, materials, mechanisms, and performance.
    Mäder K; Lehner E; Liebau A; Plontke SK
    Hear Res; 2018 Oct; 368():49-66. PubMed ID: 29576310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of therapeutics to the inner ear: The challenge of the blood-labyrinth barrier.
    Nyberg S; Abbott NJ; Shi X; Steyger PS; Dabdoub A
    Sci Transl Med; 2019 Mar; 11(482):. PubMed ID: 30842313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local drug delivery to the inner ear using biodegradable materials.
    Nakagawa T; Ito J
    Ther Deliv; 2011 Jun; 2(6):807-14. PubMed ID: 22822510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in nano-based inner ear delivery systems for the treatment of sensorineural hearing loss.
    Li L; Chao T; Brant J; O'Malley B; Tsourkas A; Li D
    Adv Drug Deliv Rev; 2017 Jan; 108():2-12. PubMed ID: 26796230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disposition of nanoparticle-based delivery system via inner ear administration.
    Chen G; Zhang X; Yang F; Mu L
    Curr Drug Metab; 2010 Dec; 11(10):886-97. PubMed ID: 21208174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug delivery to the inner ear: strategies and their therapeutic implications for sensorineural hearing loss.
    Rivera T; Sanz L; Camarero G; Varela-Nieto I
    Curr Drug Deliv; 2012 May; 9(3):231-42. PubMed ID: 22283653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trials for inner ear drugs: Design and execution challenges.
    Jung DH; Rauch SD
    Hear Res; 2018 Oct; 368():123-126. PubMed ID: 29602591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anatomical basis of drug delivery to the inner ear.
    Glueckert R; Johnson Chacko L; Rask-Andersen H; Liu W; Handschuh S; Schrott-Fischer A
    Hear Res; 2018 Oct; 368():10-27. PubMed ID: 30442227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic principles in the inner ear: Influence of drug properties on intratympanic applications.
    Salt AN; Plontke SK
    Hear Res; 2018 Oct; 368():28-40. PubMed ID: 29551306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanodelivery of antioxidant Agents: A promising strategy for preventing sensorineural hearing loss.
    Hajmohammadi Z; Bagher Z; Taghizadeh-Hesary F; Khodadadi M; Masror N; Asghari A; Valipour B; Seifalian A
    Eur J Pharm Biopharm; 2024 Sep; 202():114393. PubMed ID: 38992481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in therapeutics and drug delivery for the treatment of inner ear diseases: a patent review (2011-2015).
    Nguyen K; Kempfle JS; Jung DH; McKenna CE
    Expert Opin Ther Pat; 2017 Feb; 27(2):191-202. PubMed ID: 27855527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of intracochlear drug delivery devices in the management of inner ear disease.
    Ayoob AM; Borenstein JT
    Expert Opin Drug Deliv; 2015 Mar; 12(3):465-79. PubMed ID: 25347140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inner ear drug delivery for auditory applications.
    Swan EE; Mescher MJ; Sewell WF; Tao SL; Borenstein JT
    Adv Drug Deliv Rev; 2008 Dec; 60(15):1583-99. PubMed ID: 18848590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bile acid permeation enhancement for inner ear cochlear drug pharmacological uptake: bio-nanotechnologies in chemotherapy-induced hearing loss.
    Carey L; Walker D; Jones M; Ionescu C; Wagle S; Kovacevic B; Brown D; Mikov M; Mooranian A; Al-Salami H
    Ther Deliv; 2021 Dec; 12(12):807-819. PubMed ID: 34761700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technical note on microcatheter implantation for local inner ear drug delivery: surgical technique and safety aspects.
    Plontke SK; Zimmermann R; Zenner HP; Löwenheim H
    Otol Neurotol; 2006 Oct; 27(7):912-7. PubMed ID: 17006340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.